13JPY
16.01 BJPY
78.14 BJPY
46.06 M
About TAKARA BIO INC
Sector
Industry
Headquarters
Kusatsu
Website
Employees (FY)
1.79 K
Founded
2002
ISIN
JP3460200003
FIGI
BBG000QDCZK9
Takara Bio, Inc. engages in development and marketing of genetic engineering technologies. It provides products and services for basic research and industrial application in life sciences. These include services for the research and manufacturing of regenerative medicine products and the development of gene therapy products for synovial sarcoma. It also develops, manufactures, and sells reagents for polymerase chain reaction (PCR) tests for COVID-19. The company was founded on April 1, 2002 and is headquartered in Kusatsu, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4974 is 956 JPY — it has decreased by 0.93% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange TAKARA BIO INC stocks are traded under the ticker 4974.
TAKARA BIO INC is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
4974 stock is 1.37% volatile and has beta coefficient of 0.30. Check out the list of the most volatile stocks — is TAKARA BIO INC there?
One year price forecast for TAKARA BIO INC has a max estimate of 2200 JPY and a min estimate of 1300 JPY.
4974 earnings for the last quarter are 6.35 JPY per share, whereas the estimation was 6.50 JPY resulting in a −2.31% surprise. The estimated earnings for the next quarter are 1.40 JPY per share. See more details about TAKARA BIO INC earnings.
TAKARA BIO INC revenue for the last quarter amounts to 9.94 B JPY despite the estimated figure of 11.22 B JPY. In the next quarter revenue is expected to reach 11.82 B JPY.
Yes, you can track TAKARA BIO INC financials in yearly and quarterly reports right on TradingView.
4974 stock has fallen by 1.24% compared to the previous week, the month change is a 5.44% fall, over the last year TAKARA BIO INC has showed a 45.06% decrease.
4974 net income for the last quarter is −930.00 M JPY, while the quarter before that showed 765.00 M JPY of net income which accounts for −221.57% change. Track more TAKARA BIO INC financial stats to get the full picture.
Today TAKARA BIO INC has the market capitalization of 116.20 B, it has increased by 2.02% over the last week.
TAKARA BIO INC dividend yield was 2.42% in 2022, and payout ratio reached 31.59%. The year before the numbers were 1.47% and 20.02% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4974 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TAKARA BIO INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 1.79 K employees. See our rating of the largest employees — is TAKARA BIO INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TAKARA BIO INC technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TAKARA BIO INC stock shows the sell signal. See more of TAKARA BIO INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on TAKARA BIO INC future price: according to them, 4974 price has a max estimate of 2200.00 JPY and a min estimate of 1300.00 JPY. Read a more detailed TAKARA BIO INC forecast: see what analysts think of TAKARA BIO INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TAKARA BIO INC EBITDA is 6.54 B JPY, and current EBITDA margin is 32.35%. See more stats in TAKARA BIO INC financial statements.